insights_auto
Why is AGIO down ४.०३%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ २७.६०
arrow_downward
-४.०३%(-१.१६) 1D
US$ २७.६०
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर २०, १६:००:०० GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २८.०१
High
US$ २९.१४
Low
US$ २७.४३
Mkt. cap
१.६५ अरब
Avg. vol.
११.२८ लाख
Volume
७.७६ लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २३.०२
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २८.०१
High
US$ २९.१४
Low
US$ २७.४३
Mkt. cap
१.६५ अरब
Avg. vol.
११.२८ लाख
Volume
७.७६ लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २३.०२
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
The Motley Fool
·
१ घण्टा पहिले
Report: Goldman Sachs Predicts the S&P 500 Will Gain 26% in 12 Months
NBC26
·
११ मिनेट पहिले
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year
Yahoo Finance
·
१ घण्टा पहिले
The S&P 500 Has More Than Tripled in 10 Years, Even After Its Latest Pullback. Here’s What $1,000 in VOO Could Have Become.
FXStreet
·
४ घण्टा पहिले
Dow Jones Industrial Average drops for a fifth day as AI rout widens
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc